Replication of HIV-1 in vivo and in vitro

被引:27
作者
Orenstein, Jan Marc [1 ]
机构
[1] Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA
关键词
HIV; in vitro; in vivo; macrophage; TEM;
D O I
10.1080/01913120701344343
中图分类号
TH742 [显微镜];
学科分类号
摘要
A complex relationship exists between HIV and its cellular targets. The lethal effect of HIV on circulating CD4(+) helper T lymphocytes parallels the degree of the infected individual's immunodeficiency and ultimately the transition to AIDS and death. However, as with other members of the Lentivirus family of retroviruses, the ubiquitous, mobile macrophage is also a prime target for HIV infection, and apparently, in most instances, is the initial infected cell, since most people are infected with a CCR5 chemokine-tropic virus. Unlike the lymphocyte, the macrophage is apparently a more stable viral host, capable of a long infected life as an HIV reservoir and a chronic source of infectious virus. Published in vitro studies have indicated that whereas lymphocytes replicate HIV solely on their plasma membrane, macrophages have been envisaged to predominantly replicate HIV within cytoplasmic vacuoles, and thus have been likened to a "Trojan horse,'' when it comes to the immune system. Recent studies have revealed an ingenious way by which the cultured monocyte-derived macrophage (MDM) replicates HIV and releases it into the medium. The key macrophage organelle appears to be what is alternatively referred to as the "late endosome'' ( LE) or the "multivesicular body'' (MVB), which have a short and a long history, respectively. Proof of the association is that chemically, LE/MVB and their vesicles possess several pathopneumonic membrane markers ( e.g., CD63) that are found on released HIV particles. The hypothesis is that HIV usurps this vesicle-forming mechanism and employs it for its own replication. Release of the intravacuolar virus from the cell is hypothesized to occur by a process referred to as exocytosis, resulting from the fusion of virus-laden LE=MVB with the plasma membrane of the macrophage. Interestingly, LE=MVB are also involved in the infection stage of MDM by HIV. Close review of the literature reveals that along with the Golgi, which contributes to the formation of LE=MVB, the MVB was first identified as a site of HIV replication by macrophages many years ago, but the full implication of this observation was not appreciated at the time. As in many other areas of HIV research, what has been totally lacking is an in vivo confirmation of the in vitro phenomenon. Herein, the ultrastructure of HIV interaction with cells in vitro and in vivo is explored. It is shown that while HIV is regularly found in LE=MVB in vitro, it is infrequently the case in vivo. Therefore, the results challenge the "Trojan horse'' concept.
引用
收藏
页码:151 / 167
页数:17
相关论文
共 50 条
  • [31] Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals
    Rosok, B
    Voltersvik, P
    Bjerknes, R
    Axelsson, M
    Haaheim, LR
    Asjo, B
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (02) : 203 - 207
  • [32] Controlling the Replication of a Genomically Recoded HIV-1 with a Functional Quadruplet Codon in Mammalian Cells
    Chen, Yan
    Wan, Yanmin
    Wang, Nanxi
    Yuan, Zhe
    Niu, Wei
    Li, Qingsheng
    Guo, Jiantao
    ACS SYNTHETIC BIOLOGY, 2018, 7 (06): : 1612 - 1617
  • [33] Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle
    Daelemans, Dirk
    Dumont, Jean-Maurice
    Rosenwirth, Brigitte
    De Clercq, Erik
    Pannecouque, Christophe
    ANTIVIRAL RESEARCH, 2010, 85 (02) : 418 - 421
  • [34] Nef and TNFα are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages
    Herbein, Georges
    Varin, Audrey
    Larbi, Anis
    Fortin, Carl
    Mahlknecht, Ulrich
    Fulop, Tamas
    Aggarwal, Bharat B.
    CURRENT HIV RESEARCH, 2008, 6 (02) : 117 - 129
  • [35] Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis
    De Haas, CJC
    De Vos, NM
    Visser, MR
    Snippe, H
    Verhoef, J
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 111 (02) : 286 - 292
  • [36] HIV-1 pol replication capacity predicts disease progression
    Daar, ES
    Kesler, KL
    Wrin, T
    Petropoulo, CJ
    Bates, M
    Lail, A
    Hellmann, NS
    Gomperts, E
    Donfield, S
    AIDS, 2005, 19 (09) : 871 - 877
  • [37] Investigation of the HIV-1 matrix interactome during virus replication
    Li, Yan
    Frederick, Kristin M.
    Haverland, Nicole A.
    Ciborowski, Pawel
    Belshan, Michael
    PROTEOMICS CLINICAL APPLICATIONS, 2016, 10 (02) : 156 - 163
  • [38] Tetraspanin CD63 is a regulator of HIV-1 replication
    Fu, Enqing
    Pan, Lei
    Xie, Yonghong
    Mu, Deguang
    Liu, Wei
    Jin, Faguang
    Bai, Xuefan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1184 - 1198
  • [39] Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo
    Sassi, Atfa
    Brichacek, Beda
    Hieny, Sara
    Yarovinsky, Felix
    Golding, Hana
    Grivel, Jean-Charles
    Sher, Alan
    Margolis, Leonid
    MICROBES AND INFECTION, 2009, 11 (14-15) : 1106 - 1113
  • [40] Macrophages and HIV-1
    Cobos-Jimenez, Viviana
    Booiman, Thijs
    Hamann, Jorg
    Kootstra, Neeltje A.
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (05) : 385 - 390